Synergy CHC Corp. (SNYR)

Synergy CHC Corp. provides consumer health and beauty products across the United States, Canada, and the United Kingdom. Their brand portfolio includes FOCUSfactor, Flat Tummy, and Hand MD, distributed through retail, online channels, and television advertising.

51/100 AI Score MCap 16M Vol 11K

Company Overview

CEOJack Ross
Employees21
HeadquartersWestbrook, ME, US
IPO Year2014

Synergy CHC Corp. offers a diverse portfolio of consumer health and beauty brands, including FOCUSfactor and Flat Tummy, with a strong gross margin of 71.0%, targeting health-conscious consumers through multiple distribution channels and strategic marketing campaigns.

Investment Thesis

Synergy CHC Corp. presents a compelling investment opportunity within the consumer health and beauty sector, driven by its diverse brand portfolio and multi-channel distribution strategy. The company's strong gross margin of 71.0% indicates efficient cost management and brand pricing power. Key value drivers include the continued growth of its FOCUSfactor brain health supplements, the expansion of the Flat Tummy lifestyle brand, and the increasing demand for Hand MD skincare products. Upcoming catalysts include potential partnerships with major retailers and expansion into new international markets. With a P/E ratio of 6.93, SNYR offers a potentially undervalued entry point, contingent on successful execution of its growth strategies and continued profitability.

Key Highlights

  • Market capitalization of $0.02 billion reflects the company's current valuation in the market.
  • P/E ratio of 6.93 suggests a potentially undervalued stock compared to industry peers.
  • Gross margin of 71.0% indicates strong pricing power and efficient cost management.
  • Profit margin of 7.5% demonstrates the company's ability to generate profits from its sales.
  • Beta of 0.93 indicates that the stock is slightly less volatile than the overall market.

Competitors

Strengths

  • Established brand portfolio with FOCUSfactor and Flat Tummy.
  • Multi-channel distribution network.
  • High gross margins.
  • Experienced management team.

Weaknesses

  • Small market capitalization.
  • Limited financial resources.
  • Dependence on a few key brands.
  • High marketing expenses.

Catalysts

  • Upcoming: Potential partnerships with major retailers to expand distribution.
  • Upcoming: Expansion into new international markets, particularly in Europe and Asia.
  • Ongoing: Continued growth of the FOCUSfactor brand and product line.
  • Ongoing: E-commerce optimization and digital marketing efforts.
  • Ongoing: Product innovation and development to meet evolving consumer needs.

Risks

  • Potential: Intense competition from larger and more established companies.
  • Potential: Changing consumer preferences and trends.
  • Potential: Regulatory changes affecting the consumer health and beauty industry.
  • Ongoing: Dependence on a few key brands for revenue generation.
  • Ongoing: High marketing expenses required to maintain brand visibility.

Growth Opportunities

  • Expansion of FOCUSfactor Brand: The market for brain health supplements is experiencing significant growth, driven by an aging population and increasing awareness of cognitive health. Synergy CHC Corp. can capitalize on this trend by expanding the FOCUSfactor product line with new formulations and targeted marketing campaigns. The global brain health supplements market is projected to reach $10.7 billion by 2027, offering a substantial growth opportunity for Synergy CHC Corp. Timeline: Ongoing.
  • Strategic Partnerships with Retailers: Collaborating with major retailers can significantly expand Synergy CHC Corp.'s distribution network and increase brand visibility. By securing shelf space in prominent retail chains, the company can reach a broader consumer base and drive sales growth. This strategy aligns with the ongoing trend of consumers seeking convenient access to health and beauty products. Timeline: Upcoming, within the next 12-18 months.
  • International Market Expansion: Expanding into new international markets, particularly in Europe and Asia, represents a significant growth opportunity for Synergy CHC Corp. By adapting its product offerings to local preferences and establishing strategic partnerships with distributors, the company can tap into new revenue streams and diversify its geographic footprint. Timeline: Upcoming, phased approach over the next 2-3 years.
  • E-commerce Optimization: Enhancing the company's e-commerce platform and digital marketing efforts can drive online sales and improve customer engagement. By investing in user-friendly website design, targeted advertising campaigns, and social media marketing, Synergy CHC Corp. can attract new customers and increase brand loyalty. The global e-commerce market is expected to continue its strong growth trajectory, providing a favorable backdrop for this strategy. Timeline: Ongoing.
  • Product Innovation and Development: Investing in research and development to create new and innovative products can help Synergy CHC Corp. maintain a competitive edge and attract new customers. By staying ahead of consumer trends and developing products that address unmet needs, the company can drive long-term growth and increase its market share. This includes exploring new formulations, delivery methods, and product categories within the health and beauty space. Timeline: Ongoing.

Opportunities

  • Expansion into new international markets.
  • Strategic partnerships with major retailers.
  • Product innovation and development.
  • E-commerce optimization.

Threats

  • Intense competition in the consumer health and beauty market.
  • Changing consumer preferences.
  • Regulatory changes.
  • Economic downturn.

Competitive Advantages

  • Established Brand Portfolio: Synergy CHC Corp. has built a portfolio of recognized brands, including FOCUSfactor and Flat Tummy, which have gained consumer trust and loyalty.
  • Multi-Channel Distribution Network: The company's ability to distribute its products through multiple channels, including retail, online, and television advertising, provides a competitive advantage.
  • Strong Gross Margins: The company's high gross margins indicate efficient cost management and brand pricing power.
  • Proprietary Formulations: The company's unique product formulations and intellectual property provide a barrier to entry for competitors.

About

Synergy CHC Corp., headquartered in Westbrook, Maine, has evolved into a provider of consumer health, beauty, and lifestyle products across the United States, Canada, and the United Kingdom. Originally incorporated in 2010 as Synergy Strips Corp., the company rebranded in August 2015 to Synergy CHC Corp., reflecting its expanded focus on consumer healthcare. The company's portfolio includes brain health nutritional supplements under the FOCUSfactor brand, lifestyle products and accessories under the Flat Tummy brand, and anti-aging skincare products under the Hand MD brand. FOCUSfactor offers nutritional supplements designed to enhance cognitive function and brain health. Flat Tummy provides lifestyle products, including tea, shakes, lollipops, supplements, apparel, and exercise accessories, targeting consumers focused on wellness and weight management. Hand MD offers anti-aging skincare products, such as serums and creams for exfoliating, skin repair, and rehydration, as well as hand soaps and hand sanitizers. Synergy CHC Corp. distributes its products through a multi-channel approach, including retailers, television advertising campaigns, and online sales, allowing the company to reach a broad consumer base. With a market capitalization of $0.02 billion and a profit margin of 7.5%, Synergy CHC Corp. continues to focus on expanding its brand presence and product offerings within the consumer health and beauty market.

What They Do

  • Develops and markets brain health nutritional supplements under the FOCUSfactor brand.
  • Offers lifestyle products and accessories, including tea, shakes, and apparel under the Flat Tummy brand.
  • Provides anti-aging skincare products, such as serums and creams, under the Hand MD brand.
  • Sells its products through retailers in the United States, Canada, and the United Kingdom.
  • Utilizes television advertising campaigns to promote its brands and products.
  • Distributes products through online channels, including its own website and third-party e-commerce platforms.

Business Model

  • Develops and markets consumer health, beauty, and lifestyle products.
  • Generates revenue through direct sales to retailers and consumers.
  • Utilizes a multi-channel distribution strategy, including retail, online, and television advertising.
  • Focuses on brand building and marketing to drive sales and customer loyalty.

Industry Context

Synergy CHC Corp. operates in the competitive consumer health and beauty market, which is characterized by evolving consumer preferences and increasing demand for health and wellness products. The industry is driven by trends such as personalized skincare, natural and organic ingredients, and the growing popularity of e-commerce. Synergy CHC Corp. competes with companies like ADGM (Adagio Medical), ALLR (Allarity Therapeutics), CING (Cingulate), CLSD (Clearside Biomedical), and COCH (COCHLEAR LTD), all vying for market share within specific niches. The company's success depends on its ability to innovate, adapt to changing consumer trends, and effectively market its products through various distribution channels.

Key Customers

  • Health-conscious consumers seeking brain health supplements.
  • Individuals interested in weight management and lifestyle products.
  • Consumers looking for anti-aging skincare solutions.
  • Retailers who distribute consumer health and beauty products.
AI Confidence: 72% Updated: 2/9/2026

Financials

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q3 2025 $8M $125,327 $0.01
Q2 2025 $8M $1M $0.17
Q1 2025 $8M $876,264 $0.10
Q4 2024 $10M $105,667 $0.01

Source: Company filings

Chart & Info

Price Chart

Synergy CHC Corp. (SNYR) stock price: $1.83 (-0.05, -2.66%)

Latest News

Technical Analysis

RSI(14)
--
MACD
--
Volume
10,046

Rationale

AI-generated technical analysis for SNYR including trend direction, momentum, and pattern recognition.

What to Watch

Key support and resistance levels, volume signals, and upcoming events.

Risk Management

Position sizing, stop-loss levels, and risk-reward assessment.

Community

Discussion

Share your analysis and discuss Synergy CHC Corp. (SNYR) with other investors. Log in to post.

Sentiment

Community sentiment and discussion activity for SNYR.

Make a Prediction

Set your price target for Synergy CHC Corp. (SNYR), choose a timeframe, and track your prediction accuracy.

Current price: $1.83

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SNYR.

Price Targets

Wall Street price target analysis for SNYR.

Insider Flow (30d)

No insider trades in the last 30 days.

MoonshotScore

50.5/100

Score Factors

  • Revenue Growth 5/100

    Revenue growth data is currently unavailable for this company.

  • Gross Margin 10/100

    Gross margin of 71.1% shows excellent pricing power and a strong competitive moat.

  • Operating Leverage 4/100

    Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.

  • Cash Runway 5/100

    Cash position data is currently unavailable for this company.

  • R&D Intensity 5/100

    R&D spending data is currently unavailable for this company.

  • Insider Activity 6/100

    No significant insider buying or selling recently, which is neutral for the stock outlook.

  • Short Interest 5/100

    Float and volume data unavailable for liquidity analysis.

  • Price Momentum 0/100

    No bullish technical signals detected. The stock lacks upward price momentum currently.

  • News Sentiment 5/100

    No sentiment data available

What does this score mean?

The MoonshotScore rates SNYR's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Frequently Asked Questions

What does Synergy CHC Corp. do?

Synergy CHC Corp. is a consumer health and beauty company that develops, markets, and distributes a range of products across the United States, Canada, and the United Kingdom. Its brand portfolio includes FOCUSfactor, Flat Tummy, and Hand MD, which cater to different consumer needs, such as brain health, weight management, and skincare. The company utilizes a multi-channel distribution strategy, including retail partnerships, online sales, and television advertising, to reach a broad customer base and drive sales growth.

Is SNYR stock a good buy?

SNYR stock presents a mixed investment profile. The company's strong gross margin of 71.0% and low P/E ratio of 6.93 suggest potential undervaluation. However, its small market capitalization and dependence on a few key brands pose risks. The potential for growth lies in expanding the FOCUSfactor brand, securing strategic retail partnerships, and entering new international markets. Investors should carefully weigh these factors and consider their risk tolerance before investing.

What are the main risks for SNYR?

Synergy CHC Corp. faces several risks, including intense competition in the consumer health and beauty market, changing consumer preferences, and regulatory changes. The company's dependence on a few key brands makes it vulnerable to shifts in consumer demand. Additionally, high marketing expenses are required to maintain brand visibility and compete effectively. An economic downturn could also negatively impact consumer spending on discretionary items, such as health and beauty products.

Is SNYR a good stock to buy?

Whether SNYR is a good investment depends on your financial goals, risk tolerance, and investment horizon. Key factors to evaluate include the company's revenue growth trajectory, profit margins, debt-to-equity ratio, competitive moat, and valuation multiples (P/E, P/S, EV/EBITDA) relative to industry peers. Our AI-generated Investment Thesis and SWOT analysis on this page provide a data-driven starting point. Always do your own research and consider consulting a financial advisor before making investment decisions.

What is the SNYR MoonshotScore?

The MoonshotScore for SNYR is an AI-powered rating from 0 to 100 that evaluates a stock across four dimensions: growth potential (revenue and earnings trajectory), financial health (balance sheet strength, cash flow), market momentum (price trends, volume patterns, institutional flows), and risk factors (volatility, debt levels, sector headwinds). Scores above 70 indicate strong potential, 50-70 moderate, and below 50 suggests caution. The score is recalculated daily using the latest financial data and market signals.

How often is SNYR data updated?

SNYR stock prices are updated in real-time during U.S. market hours (9:30 AM - 4:00 PM ET, Monday through Friday). After-hours and pre-market prices are also tracked. Company fundamentals (earnings, revenue, balance sheet) are refreshed when new quarterly or annual reports are filed. Analyst ratings, price targets, and AI-generated insights are updated daily. Breaking news related to SNYR is aggregated continuously from premium financial news sources throughout the day.

What are the growth catalysts for SNYR?

Growth catalysts for Synergy CHC Corp. (SNYR) can include several categories: product catalysts (new launches, FDA approvals, patent grants), financial catalysts (earnings beats, margin expansion, share buybacks), strategic catalysts (acquisitions, partnerships, market expansion into new regions), and macro catalysts (favorable regulation, industry tailwinds, secular growth trends). Our AI analyzes Synergy CHC Corp.'s specific catalysts using earnings transcripts, SEC filings, and news sentiment to identify the most impactful near-term and long-term drivers.

Who are SNYR's main competitors?

Synergy CHC Corp. (SNYR) competes with companies in its industry that target similar customers, markets, or product categories. Competitor analysis involves comparing key metrics: market share, revenue growth rates, profit margins, R&D spending, and valuation multiples. Understanding competitive positioning helps investors assess whether SNYR has a sustainable competitive advantage (moat) through brand strength, network effects, cost leadership, or switching costs. Our Competitors section provides a side-by-side comparison with relevant peers.

What do analysts say about SNYR?

Wall Street analyst coverage for SNYR includes consensus ratings (buy, hold, or sell), 12-month price targets, and earnings estimates. Analyst opinions are aggregated from major investment banks and research firms. Key metrics to watch include the consensus price target (average, high, and low estimates), the number of analysts covering the stock, any recent rating changes (upgrades or downgrades), and how actual earnings compare to analyst estimates (beat or miss history). Our platform aggregates these from multiple data providers for a comprehensive view.

What is SNYR's market cap?

Market capitalization (market cap) for SNYR is calculated by multiplying the current share price by the total number of outstanding shares. It represents the market's total valuation of the company. Stocks are typically categorized as mega-cap ($200B+), large-cap ($10B-$200B), mid-cap ($2B-$10B), small-cap ($300M-$2B), or micro-cap (under $300M). Market cap influences index inclusion, institutional ownership eligibility, and risk profile. Our Key Statistics section shows SNYR's current market cap alongside enterprise value and other valuation metrics.

How has SNYR stock performed recently?

SNYR's recent stock performance can be evaluated across multiple timeframes: daily price changes, week-over-week momentum, monthly trends, and year-to-date returns. Important performance indicators include the stock's 52-week high and low, moving averages (50-day and 200-day SMA), relative strength index (RSI), and volume trends. Comparing SNYR's performance against its sector index and the S&P 500 provides context on whether it is outperforming or underperforming the broader market.

What are the risks of investing in SNYR?

Key risk categories for SNYR include: market risk (overall market downturns affecting stock prices), company-specific risk (management changes, product failures, competitive threats), financial risk (high debt levels, cash burn, dilution from stock issuance), regulatory risk (government policy changes, lawsuits, compliance issues), and macroeconomic risk (interest rate changes, inflation, currency fluctuations). Beta measures SNYR's volatility relative to the market - a beta above 1.0 means higher volatility than the S&P 500. Our AI-generated risk assessment identifies the most relevant risk factors for this specific stock.

Are insiders buying or selling SNYR?

Insider trading activity for SNYR tracks purchases and sales by company executives, directors, and major shareholders (10%+ owners) as reported in SEC Form 4 filings. Insider buying is generally considered a bullish signal because insiders have the deepest knowledge of company operations, while selling may have various motivations (diversification, tax planning, pre-planned 10b5-1 trading plans). Key metrics include the buy-to-sell ratio, total dollar value of insider transactions, and whether multiple insiders are trading in the same direction. Our Insider Flow tab shows recent transactions with dates and dollar amounts.

Is SNYR a good stock for beginners?

Synergy CHC Corp. (SNYR) can be suitable for beginner investors depending on several factors. Look at the MoonshotScore on this page for an overall AI-powered assessment of growth potential and risk. Beginners should also check the company's market cap (larger companies tend to be less volatile), gross margin (higher margins mean stronger business fundamentals), and cash position (healthy cash reduces bankruptcy risk). Always start with a small position size and never invest money you cannot afford to lose.

How risky is SNYR for first-time investors?

Every stock carries risk, including Synergy CHC Corp. (SNYR). First-time investors should review the Risk Factors section on this page for company-specific risks. Key risk indicators include price volatility (check the chart for daily swings), insider selling activity (see Insider Flow tab), and cash runway (see MoonshotScore breakdown). A diversified portfolio with an index fund like the S&P 500 as a core holding is generally recommended before adding individual stocks like SNYR.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Data provided for informational purposes only.

AI Analysis Notes
  • Financial data is based on publicly available information and may be subject to change.
  • Analysis is based on current market conditions and may not be indicative of future performance.
Data Sources
profilefundamentalsexistingCopy